Concepts (230)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hearing Loss | 17 | 2024 | 55 | 4.270 |
Why?
|
| Nutrition Surveys | 12 | 2025 | 145 | 2.220 |
Why?
|
| Olfaction Disorders | 5 | 2021 | 15 | 1.810 |
Why?
|
| Auditory Threshold | 4 | 2025 | 26 | 1.620 |
Why?
|
| HIV Infections | 15 | 2025 | 965 | 1.250 |
Why?
|
| Health Surveys | 6 | 2016 | 318 | 1.160 |
Why?
|
| Hearing Loss, Noise-Induced | 2 | 2025 | 5 | 1.020 |
Why?
|
| Noise, Occupational | 2 | 2025 | 13 | 1.020 |
Why?
|
| Otitis Media | 3 | 2016 | 12 | 1.010 |
Why?
|
| Occupational Diseases | 2 | 2025 | 270 | 0.870 |
Why?
|
| Prevalence | 21 | 2019 | 1441 | 0.760 |
Why?
|
| Pregnancy Complications, Infectious | 6 | 2025 | 70 | 0.720 |
Why?
|
| Hearing Disorders | 5 | 2015 | 10 | 0.670 |
Why?
|
| Feeding Behavior | 1 | 2021 | 265 | 0.620 |
Why?
|
| Prenatal Exposure Delayed Effects | 5 | 2021 | 160 | 0.560 |
Why?
|
| Infectious Disease Transmission, Vertical | 7 | 2025 | 80 | 0.560 |
Why?
|
| United States | 23 | 2025 | 8130 | 0.540 |
Why?
|
| Gasoline | 1 | 2017 | 4 | 0.540 |
Why?
|
| Female | 50 | 2025 | 34113 | 0.540 |
Why?
|
| Hearing Loss, Sensorineural | 4 | 2025 | 39 | 0.530 |
Why?
|
| Anti-HIV Agents | 3 | 2025 | 146 | 0.530 |
Why?
|
| Tinnitus | 2 | 2016 | 16 | 0.500 |
Why?
|
| Middle Ear Ventilation | 1 | 2016 | 3 | 0.500 |
Why?
|
| Humans | 59 | 2025 | 65534 | 0.490 |
Why?
|
| Male | 44 | 2025 | 31065 | 0.490 |
Why?
|
| Adult | 30 | 2025 | 17409 | 0.460 |
Why?
|
| Taste | 3 | 2021 | 39 | 0.460 |
Why?
|
| Aged | 25 | 2025 | 14941 | 0.420 |
Why?
|
| Child | 17 | 2023 | 4681 | 0.420 |
Why?
|
| Smell | 2 | 2015 | 28 | 0.420 |
Why?
|
| Otoacoustic Emissions, Spontaneous | 4 | 2021 | 8 | 0.410 |
Why?
|
| Population Surveillance | 2 | 2018 | 210 | 0.400 |
Why?
|
| Middle Aged | 24 | 2025 | 18261 | 0.400 |
Why?
|
| Vertigo | 3 | 2019 | 18 | 0.390 |
Why?
|
| Risk Factors | 20 | 2025 | 5441 | 0.380 |
Why?
|
| Young Adult | 13 | 2025 | 4831 | 0.380 |
Why?
|
| Self Report | 3 | 2021 | 392 | 0.370 |
Why?
|
| Presbycusis | 1 | 2012 | 5 | 0.370 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2023 | 136 | 0.370 |
Why?
|
| Income | 3 | 2024 | 175 | 0.360 |
Why?
|
| Healthcare Disparities | 1 | 2016 | 403 | 0.350 |
Why?
|
| Adolescent | 17 | 2023 | 6377 | 0.340 |
Why?
|
| Infant | 8 | 2025 | 1718 | 0.330 |
Why?
|
| Pregnancy | 11 | 2025 | 2432 | 0.330 |
Why?
|
| Anti-Retroviral Agents | 4 | 2023 | 75 | 0.320 |
Why?
|
| Hearing | 4 | 2023 | 27 | 0.320 |
Why?
|
| Sensation Disorders | 3 | 2016 | 22 | 0.310 |
Why?
|
| Cigarette Smoking | 2 | 2021 | 58 | 0.310 |
Why?
|
| Taste Disorders | 1 | 2009 | 1 | 0.310 |
Why?
|
| Audiometry | 6 | 2016 | 13 | 0.300 |
Why?
|
| Developmental Disabilities | 3 | 2019 | 119 | 0.300 |
Why?
|
| Epidemiologic Studies | 1 | 2009 | 34 | 0.300 |
Why?
|
| Child, Preschool | 9 | 2025 | 2077 | 0.290 |
Why?
|
| Longitudinal Studies | 8 | 2025 | 1287 | 0.290 |
Why?
|
| Audiometry, Pure-Tone | 6 | 2024 | 29 | 0.290 |
Why?
|
| Birth Weight | 3 | 2025 | 86 | 0.270 |
Why?
|
| Speech Perception | 2 | 2020 | 77 | 0.260 |
Why?
|
| Cohort Studies | 8 | 2024 | 2632 | 0.250 |
Why?
|
| Cognition Disorders | 2 | 2019 | 223 | 0.240 |
Why?
|
| Dizziness | 2 | 2016 | 18 | 0.240 |
Why?
|
| Language Development Disorders | 2 | 2018 | 26 | 0.240 |
Why?
|
| Receptor, Serotonin, 5-HT1A | 1 | 2025 | 4 | 0.240 |
Why?
|
| Receptors, Serotonin | 1 | 2025 | 17 | 0.230 |
Why?
|
| Norway | 4 | 2024 | 23 | 0.230 |
Why?
|
| Brain Stem | 1 | 2025 | 28 | 0.230 |
Why?
|
| Sudden Infant Death | 1 | 2025 | 28 | 0.230 |
Why?
|
| Educational Status | 2 | 2025 | 279 | 0.220 |
Why?
|
| Otitis Media with Effusion | 2 | 2016 | 8 | 0.220 |
Why?
|
| Surveys and Questionnaires | 7 | 2022 | 2781 | 0.220 |
Why?
|
| Postural Balance | 3 | 2016 | 66 | 0.220 |
Why?
|
| Otitis Media, Suppurative | 2 | 2015 | 3 | 0.220 |
Why?
|
| Language Disorders | 2 | 2016 | 25 | 0.220 |
Why?
|
| Aging | 3 | 2025 | 766 | 0.220 |
Why?
|
| Aged, 80 and over | 11 | 2025 | 5608 | 0.210 |
Why?
|
| Reference Values | 1 | 2025 | 331 | 0.210 |
Why?
|
| Vision Disorders | 3 | 2015 | 70 | 0.200 |
Why?
|
| Logistic Models | 5 | 2019 | 1282 | 0.190 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 2 | 2021 | 9 | 0.190 |
Why?
|
| Infant, Newborn | 4 | 2025 | 1451 | 0.180 |
Why?
|
| Disability Evaluation | 2 | 2019 | 218 | 0.160 |
Why?
|
| Chronic Disease | 4 | 2019 | 757 | 0.160 |
Why?
|
| Caloric Tests | 1 | 2020 | 2 | 0.160 |
Why?
|
| Ocular Motility Disorders | 1 | 2020 | 3 | 0.160 |
Why?
|
| Vestibular Evoked Myogenic Potentials | 1 | 2020 | 3 | 0.160 |
Why?
|
| Vestibular Diseases | 1 | 2020 | 8 | 0.160 |
Why?
|
| Noise | 1 | 2020 | 33 | 0.150 |
Why?
|
| International Classification of Functioning, Disability and Health | 1 | 2019 | 6 | 0.150 |
Why?
|
| World Health Organization | 1 | 2019 | 36 | 0.150 |
Why?
|
| Cross-Sectional Studies | 7 | 2024 | 2699 | 0.150 |
Why?
|
| HIV Seronegativity | 2 | 2019 | 19 | 0.150 |
Why?
|
| Prospective Studies | 8 | 2025 | 3355 | 0.150 |
Why?
|
| Multivariate Analysis | 3 | 2016 | 938 | 0.150 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2019 | 40 | 0.150 |
Why?
|
| Sex Distribution | 3 | 2016 | 250 | 0.150 |
Why?
|
| Cytomegalovirus Infections | 1 | 2019 | 69 | 0.150 |
Why?
|
| Japan | 1 | 2018 | 64 | 0.140 |
Why?
|
| Smoke | 1 | 2018 | 24 | 0.140 |
Why?
|
| Exercise | 1 | 2025 | 964 | 0.140 |
Why?
|
| Global Health | 1 | 2019 | 186 | 0.140 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2019 | 161 | 0.140 |
Why?
|
| Voice Disorders | 1 | 2016 | 5 | 0.130 |
Why?
|
| Audiometry, Speech | 1 | 2016 | 5 | 0.130 |
Why?
|
| Case-Control Studies | 4 | 2024 | 1156 | 0.120 |
Why?
|
| HIV | 2 | 2018 | 70 | 0.120 |
Why?
|
| Sex Factors | 5 | 2019 | 997 | 0.120 |
Why?
|
| Exfoliation Syndrome | 1 | 2015 | 9 | 0.120 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2016 | 29 | 0.120 |
Why?
|
| Urban Health | 1 | 2015 | 40 | 0.120 |
Why?
|
| Cognitive Dysfunction | 1 | 2020 | 351 | 0.110 |
Why?
|
| Correction of Hearing Impairment | 1 | 2015 | 3 | 0.110 |
Why?
|
| Hearing Loss, High-Frequency | 1 | 2015 | 3 | 0.110 |
Why?
|
| Arthritis | 1 | 2015 | 53 | 0.110 |
Why?
|
| Hearing Aids | 1 | 2015 | 8 | 0.110 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2015 | 50 | 0.110 |
Why?
|
| Insurance, Health | 1 | 2016 | 152 | 0.110 |
Why?
|
| Socioeconomic Factors | 4 | 2019 | 800 | 0.110 |
Why?
|
| Health Promotion | 1 | 2019 | 518 | 0.110 |
Why?
|
| Bottle Feeding | 1 | 2014 | 6 | 0.110 |
Why?
|
| Ear Diseases | 1 | 2014 | 5 | 0.110 |
Why?
|
| HIV Seropositivity | 1 | 2015 | 83 | 0.110 |
Why?
|
| Acute Disease | 1 | 2016 | 678 | 0.110 |
Why?
|
| Recurrence | 1 | 2016 | 660 | 0.110 |
Why?
|
| Cochlea | 1 | 2014 | 14 | 0.100 |
Why?
|
| Respiratory Tract Infections | 1 | 2014 | 90 | 0.100 |
Why?
|
| Activities of Daily Living | 1 | 2015 | 292 | 0.100 |
Why?
|
| Vision, Ocular | 1 | 2013 | 20 | 0.100 |
Why?
|
| Occupational Exposure | 1 | 2016 | 320 | 0.100 |
Why?
|
| Age Factors | 5 | 2019 | 1592 | 0.100 |
Why?
|
| Canada | 1 | 2013 | 155 | 0.100 |
Why?
|
| Congresses as Topic | 1 | 2013 | 80 | 0.090 |
Why?
|
| Developing Countries | 1 | 2013 | 96 | 0.090 |
Why?
|
| Breast Feeding | 1 | 2014 | 162 | 0.090 |
Why?
|
| Language Tests | 1 | 2012 | 39 | 0.090 |
Why?
|
| Quality of Life | 1 | 2019 | 1270 | 0.090 |
Why?
|
| Age Distribution | 1 | 2012 | 259 | 0.090 |
Why?
|
| Maternal Age | 2 | 2019 | 33 | 0.090 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 468 | 0.080 |
Why?
|
| Diabetes Complications | 1 | 2011 | 106 | 0.080 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2010 | 28 | 0.080 |
Why?
|
| Diabetes Mellitus | 2 | 2015 | 555 | 0.080 |
Why?
|
| Regression Analysis | 3 | 2016 | 500 | 0.080 |
Why?
|
| Iceland | 3 | 2015 | 8 | 0.070 |
Why?
|
| Pilot Projects | 2 | 2023 | 1018 | 0.070 |
Why?
|
| Retrospective Studies | 2 | 2018 | 6880 | 0.070 |
Why?
|
| Mental Disorders | 1 | 2015 | 824 | 0.070 |
Why?
|
| Depression | 1 | 2014 | 916 | 0.060 |
Why?
|
| Geriatrics | 1 | 2007 | 50 | 0.060 |
Why?
|
| Disease Susceptibility | 1 | 2007 | 167 | 0.060 |
Why?
|
| Environment | 1 | 2007 | 126 | 0.060 |
Why?
|
| Risk Assessment | 2 | 2018 | 2101 | 0.060 |
Why?
|
| Puerto Rico | 2 | 2019 | 141 | 0.060 |
Why?
|
| Hearing Tests | 1 | 2025 | 5 | 0.060 |
Why?
|
| South Africa | 1 | 2025 | 15 | 0.060 |
Why?
|
| Serotonin | 1 | 2025 | 62 | 0.060 |
Why?
|
| Mass Screening | 1 | 2010 | 706 | 0.060 |
Why?
|
| Genotype | 1 | 2007 | 679 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2007 | 401 | 0.050 |
Why?
|
| Maternal Exposure | 1 | 2004 | 43 | 0.050 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2004 | 39 | 0.050 |
Why?
|
| Cognition | 2 | 2020 | 502 | 0.050 |
Why?
|
| Environmental Pollutants | 1 | 2004 | 97 | 0.050 |
Why?
|
| Phenotype | 1 | 2007 | 1241 | 0.050 |
Why?
|
| Beds | 1 | 2003 | 10 | 0.050 |
Why?
|
| Mother-Child Relations | 1 | 2003 | 47 | 0.050 |
Why?
|
| Nonlinear Dynamics | 1 | 2022 | 26 | 0.050 |
Why?
|
| Menthol | 1 | 2021 | 6 | 0.040 |
Why?
|
| Tobacco Products | 1 | 2021 | 63 | 0.040 |
Why?
|
| Vestibular Function Tests | 1 | 2020 | 5 | 0.040 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2019 | 11 | 0.040 |
Why?
|
| Metabolism | 1 | 2019 | 13 | 0.040 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2020 | 59 | 0.040 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2020 | 94 | 0.040 |
Why?
|
| Missouri | 1 | 2019 | 10 | 0.040 |
Why?
|
| Sleep | 1 | 2003 | 239 | 0.040 |
Why?
|
| Academic Success | 1 | 2019 | 12 | 0.040 |
Why?
|
| Infant Health | 1 | 2019 | 3 | 0.040 |
Why?
|
| Anthropometry | 1 | 2019 | 87 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 1575 | 0.040 |
Why?
|
| Data Collection | 2 | 2016 | 384 | 0.040 |
Why?
|
| Child Health | 1 | 2019 | 33 | 0.040 |
Why?
|
| Cytomegalovirus | 1 | 2019 | 95 | 0.040 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2018 | 45 | 0.040 |
Why?
|
| Speech | 1 | 2018 | 64 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2019 | 492 | 0.030 |
Why?
|
| Lipids | 1 | 2019 | 328 | 0.030 |
Why?
|
| Smoking | 1 | 2021 | 866 | 0.030 |
Why?
|
| Comorbidity | 1 | 2019 | 1123 | 0.030 |
Why?
|
| Visual Field Tests | 1 | 2015 | 24 | 0.030 |
Why?
|
| Polysomnography | 1 | 2016 | 59 | 0.030 |
Why?
|
| Central America | 1 | 2015 | 2 | 0.030 |
Why?
|
| West Indies | 1 | 2015 | 6 | 0.030 |
Why?
|
| South America | 1 | 2015 | 26 | 0.030 |
Why?
|
| Visual Fields | 1 | 2015 | 51 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2019 | 888 | 0.030 |
Why?
|
| Early Medical Intervention | 1 | 2015 | 21 | 0.030 |
Why?
|
| Mexico | 1 | 2015 | 39 | 0.030 |
Why?
|
| Intraocular Pressure | 1 | 2015 | 73 | 0.030 |
Why?
|
| Confusion | 1 | 2015 | 17 | 0.030 |
Why?
|
| Urban Population | 1 | 2016 | 201 | 0.030 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2015 | 23 | 0.030 |
Why?
|
| Social Class | 1 | 2016 | 139 | 0.030 |
Why?
|
| Memory Disorders | 1 | 2015 | 53 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2014 | 2510 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 410 | 0.030 |
Why?
|
| Psychometrics | 1 | 2016 | 392 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2016 | 5817 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 2016 | 322 | 0.030 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2013 | 32 | 0.030 |
Why?
|
| Walking | 1 | 2016 | 241 | 0.030 |
Why?
|
| Urinary Tract Infections | 1 | 2014 | 96 | 0.020 |
Why?
|
| Anxiety | 1 | 2016 | 438 | 0.020 |
Why?
|
| Anxiety Disorders | 1 | 2015 | 201 | 0.020 |
Why?
|
| Osteoarthritis | 1 | 2015 | 145 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2015 | 764 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2014 | 183 | 0.020 |
Why?
|
| Cause of Death | 1 | 2013 | 223 | 0.020 |
Why?
|
| Depressive Disorder | 1 | 2015 | 288 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 426 | 0.020 |
Why?
|
| Motor Activity | 1 | 2015 | 346 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 741 | 0.020 |
Why?
|
| Hypertension | 1 | 2016 | 613 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 612 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2007 | 94 | 0.020 |
Why?
|
| Body Composition | 1 | 2007 | 154 | 0.020 |
Why?
|
| Osteoporosis | 1 | 2007 | 112 | 0.010 |
Why?
|
| Time Factors | 1 | 2013 | 3788 | 0.010 |
Why?
|
| Body Height | 1 | 2004 | 66 | 0.010 |
Why?
|
| Dementia | 1 | 2007 | 272 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2003 | 239 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2007 | 866 | 0.010 |
Why?
|